 | • レポートコード：MRC2304L188 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、250ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に462.9億ドルであった世界の医療栄養市場規模が、2022年に495.1億ドルへと拡大し、その後CAGR 7.12％で成長して2027年までに699.7億ドルに達すると予測しています。当書は、医療栄養の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、投与方法別（経腸栄養、経口栄養、非経口栄養）分析、製品原料別（果物、野菜）分析、最終用途別（癌、糖尿病、肥満、小児栄養失調、腎不全）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめています。なお、当書に掲載されている企業情報には、Abbott Laboratories、AYMES International Ltd.、B. Braun Melsungen AG.、Baxter International Inc.、Bayer AG、Cambrooke Therapeutics, Inc.、Danisco、Danone、Fresenius Kabi AG、GlaxoSmithKline Plc、Grifols S.A.、Kate Farms, Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の医療栄養市場規模：投与方法別 - 経腸栄養の市場規模 - 経口栄養の市場規模 - 非経口栄養の市場規模 ・世界の医療栄養市場規模：製品原料別 - 果物の市場規模 - 野菜の市場規模 ・世界の医療栄養市場規模：最終用途別 - 癌における市場規模 - 糖尿病における市場規模 - 肥満における市場規模 - 小児栄養失調における市場規模 - 腎不全における市場規模 ・世界の医療栄養市場規模：地域別 - 南北アメリカの医療栄養市場規模 アメリカの医療栄養市場規模 カナダの医療栄養市場規模 ブラジルの医療栄養市場規模 ... - アジア太平洋の医療栄養市場規模 日本の医療栄養市場規模 中国の医療栄養市場規模 インドの医療栄養市場規模 韓国の医療栄養市場規模 台湾の医療栄養市場規模 ... - ヨーロッパ/中東/アフリカの医療栄養市場規模 イギリスの医療栄養市場規模 ドイツの医療栄養市場規模 フランスの医療栄養市場規模 ロシアの医療栄養市場規模 ... - その他地域の医療栄養市場規模 ・競争状況 ・企業情報 |
The Global Medical Nutrition Market size was estimated at USD 46.29 billion in 2021 and expected to reach USD 49.51 billion in 2022, and is projected to grow at a CAGR 7.12% to reach USD 69.97 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Medical Nutrition to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Administration, the market was studied across Enteral Nutrition, Oral, and Parenteral Nutrition.
Based on Product Source, the market was studied across Fruits and Vegetables.
Based on End User, the market was studied across Cancer, Diabetes, Obesity, Pediatric Malnutrition, Renal Failure, and Sarcopenia.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Medical Nutrition market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Medical Nutrition Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Medical Nutrition Market, including Abbott Laboratories, AYMES International Ltd., B. Braun Melsungen AG., Baxter International Inc., Bayer AG, Cambrooke Therapeutics, Inc., Danisco, Danone, Fresenius Kabi AG, GlaxoSmithKline Plc, Grifols S.A., Kate Farms, Inc., Mead Johnson & Company, LLC, Medifood GmbH, Medtrition Inc., Meiji Holdings Co., Ltd., Nestlé S.A., Nutricia Advanced Medical Nutrition, NUTRICIÓN MÉDICA SL, Otsuka Pharmaceutical Europe Ltd., Perrigo Company plc, Primus Pharmaceuticals, Sanofi Baxter Healthcare Corporation Fresenius Kabi AG, Sichuan Kelun Pharmaceutical Co., Ltd., Solace Nutrition, and Victus, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Medical Nutrition Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Medical Nutrition Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Medical Nutrition Market?
4. What is the competitive strategic window for opportunities in the Global Medical Nutrition Market?
5. What are the technology trends and regulatory frameworks in the Global Medical Nutrition Market?
6. What is the market share of the leading vendors in the Global Medical Nutrition Market?
7. What modes and strategic moves are considered suitable for entering the Global Medical Nutrition Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need to address nutritional insufficiencies due to disease, disorder or condition
5.1.1.2. Increased product availability across major healthcare settings
5.1.1.3. Rapid aging population and its related diseases such as Parkinson’s, diabetes, and organ failure
5.1.2. Restraints
5.1.2.1. Affordability issues with prominent brands
5.1.3. Opportunities
5.1.3.1. Growing advancements with robust research and development activities for customized products
5.1.3.2. Rising awareness of infant nutrition value worldwide
5.1.4. Challenges
5.1.4.1. Lack of reimbursement policies by governments in several countries
5.1.4.2. Strict mandates from government pertinent to supplements
5.2. Cumulative Impact of COVID-19
6. Medical Nutrition Market, by Administration
6.1. Introduction
6.2. Enteral Nutrition
6.3. Oral
6.4. Parenteral Nutrition
7. Medical Nutrition Market, by Product Source
7.1. Introduction
7.2. Fruits
7.3. Vegetables
8. Medical Nutrition Market, by End User
8.1. Introduction
8.2. Cancer
8.3. Diabetes
8.4. Obesity
8.5. Pediatric Malnutrition
8.6. Renal Failure
8.7. Sarcopenia
9. Americas Medical Nutrition Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Medical Nutrition Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Medical Nutrition Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. AYMES International Ltd.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. B. Braun Melsungen AG.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Baxter International Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Bayer AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cambrooke Therapeutics, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Danisco
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Danone
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Fresenius Kabi AG
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. GlaxoSmithKline Plc
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Grifols S.A.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Kate Farms, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Mead Johnson & Company, LLC
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Medifood GmbH
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Medtrition Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Meiji Holdings Co., Ltd.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Nestlé S.A.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Nutricia Advanced Medical Nutrition
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. NUTRICIÓN MÉDICA SL
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Otsuka Pharmaceutical Europe Ltd.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Perrigo Company plc
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Primus Pharmaceuticals
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Sanofi Baxter Healthcare Corporation Fresenius Kabi AG
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Sichuan Kelun Pharmaceutical Co., Ltd.
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Solace Nutrition
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. Victus, Inc.
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing